Sara Bolin

1.1k total citations
13 papers, 411 citations indexed

About

Sara Bolin is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sara Bolin has authored 13 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Sara Bolin's work include Glioma Diagnosis and Treatment (4 papers), Chromatin Remodeling and Cancer (4 papers) and Protein Degradation and Inhibitors (4 papers). Sara Bolin is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Chromatin Remodeling and Cancer (4 papers) and Protein Degradation and Inhibitors (4 papers). Sara Bolin collaborates with scholars based in United States, Sweden and Canada. Sara Bolin's co-authors include Fredrik J. Swartling, Holger Weishaupt, Anders Sundström, Lars Hellman, Thorsten B. Feyerabend, Sonja Hutter, Hans-Reimer Rodewald, Ananya Roy, Susan Schlenner and Lena Kjellén and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer Research.

In The Last Decade

Sara Bolin

13 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Bolin United States	10	225	135	90	70	61	13	411
Unice J.K. Soh United States	5	299 1.3×	106 0.8×	136 1.5×	39 0.6×	90 1.5×	5	640
Nicholas Bockett New Zealand	10	302 1.3×	82 0.6×	38 0.4×	51 0.7×	80 1.3×	21	497
Leonidas Arvanitis United States	11	202 0.9×	54 0.4×	86 1.0×	106 1.5×	47 0.8×	50	418
Johanna Melo‐Cardenas United States	13	398 1.8×	160 1.2×	82 0.9×	122 1.7×	34 0.6×	26	701
Toshiko Yamochi Japan	8	161 0.7×	139 1.0×	75 0.8×	204 2.9×	67 1.1×	9	461
Ganesan Keerthivasan United States	9	283 1.3×	89 0.7×	65 0.7×	76 1.1×	49 0.8×	13	489
Julie Sesen United States	8	250 1.1×	36 0.3×	94 1.0×	69 1.0×	120 2.0×	13	413
D. Alice United States	11	249 1.1×	72 0.5×	116 1.3×	38 0.5×	16 0.3×	24	602
Hamda Al Thawadi Qatar	5	291 1.3×	49 0.4×	60 0.7×	92 1.3×	141 2.3×	6	464
Yuumi Okuzono Japan	10	135 0.6×	202 1.5×	31 0.3×	122 1.7×	52 0.9×	15	470

Countries citing papers authored by Sara Bolin

Since Specialization

Citations

This map shows the geographic impact of Sara Bolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Bolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Bolin more than expected).

Fields of papers citing papers by Sara Bolin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Bolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Bolin. The network helps show where Sara Bolin may publish in the future.

Co-authorship network of co-authors of Sara Bolin

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Bolin. A scholar is included among the top collaborators of Sara Bolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Bolin. Sara Bolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Nitta, Ryan T., et al.. (2019). Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene. 39(9). 2029–2029. 2 indexed citations

Bengtsson, Johan, Sara Bolin, Bengt Westermark, et al.. (2019). BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. Cell Death and Disease. 10(12). 881–881. 25 indexed citations

Prolo, Laura M., Amy Li, Scott F. Owen, et al.. (2019). Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion. Scientific Reports. 9(1). 14020–14020. 42 indexed citations

Nitta, Ryan T., et al.. (2019). Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene. 38(42). 6867–6879. 19 indexed citations

Zhang, Xing‐Mei, Sara Bolin, Anne‐Laure Joly, et al.. (2018). Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity. iScience. 9. 71–83. 38 indexed citations

Bolin, Sara, C. Persson, Anders Sundström, et al.. (2018). Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma. Oncogene. 37(21). 2850–2862. 62 indexed citations

Nitta, Ryan T., et al.. (2018). Abstract LB-322: Casein kinase 2 is a major regulator of medulloblastoma growth. Cancer Research. 78(13_Supplement). LB–322. 1 indexed citations

Hutter, Sonja, Sara Bolin, Holger Weishaupt, & Fredrik J. Swartling. (2017). Modeling and Targeting MYC Genes in Childhood Brain Tumors. Genes. 8(4). 107–107. 24 indexed citations

Rahmanto, Aldwin Suryo, Sara Bolin, Holger Weishaupt, et al.. (2016). FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. The EMBO Journal. 35(20). 2192–2212. 62 indexed citations

10.

Bolin, Sara, C. Persson, Anders Sundström, et al.. (2016). Abstract 2473: Combined BET-bromodomain and CDK2 inhibition in MYC-driven medulloblastoma. Cancer Research. 76(14_Supplement). 2473–2473. 3 indexed citations

11.

Roy, Ananya, Sara Bolin, Susan Schlenner, et al.. (2013). Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation. Journal of Biological Chemistry. 289(1). 237–250. 105 indexed citations

12.

Swartling, Fredrik J., Sara Bolin, Joanna J. Phillips, & Anders I. Persson. (2013). Signals that regulate the oncogenic fate of neural stem cells and progenitors. Experimental Neurology. 260. 56–68. 17 indexed citations

13.

Bergström, Christel A. S., et al.. (2009). Hepatitis C virus NS3 protease inhibitors: Large, flexible molecules of peptide origin show satisfactory permeability across Caco-2 cells. European Journal of Pharmaceutical Sciences. 38(5). 556–563. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact